Rymedi

Rymedi is a healthcare data exchange platform that utilizes blockchain technology to streamline the transfer of medical records and data securely. The company offers a decentralized data platform that addresses longstanding roadblocks faced by healthcare systems, such as data entry errors and compliance issues. Rymedi's innovative solution automates data transfer with flexible interoperability, streamlines data entry with real-time results, and meets global regulatory compliance standards with unrivaled security.

In the areas of occupational health, clinical trials, and laboratory information management systems, Rymedi's platform facilitates seamless data access across multiple parties and platforms. As of October 2023, the company served over 1 million patients across 1,200 locations in the US, Africa, and Australia. Rymedi's cloud-based architecture enables rapid implementation, with the ability to connect organizations with customers and patients within days.

Key customers and partnerships

In May 2024, Rymedi announced a strategic partnership with Precision Genetics to advance precision medicine and healthcare innovation. This collaboration integrated Precision Genetics' personalized solution to reduce adverse drug reactions with Rymedi's blockchain-enabled clinical trial and registry platform.

Rymedi has supported notable organizations like Clemson University, which utilized the platform for campus-wide Covid-19 testing in 2022. The university's testing program, facilitated by Rymedi's automated workflows, enabled efficient mass testing of over 30,000 students, faculty, and staff members.

Additionally, Rymedi has provided its all-in-one solution to Beechtree Diagnostics, encompassing patient registration, reporting to clients, and direct patient communication, thereby reducing lab costs through its automated and integrated platform.